Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia

Atherosclerosis

Volumn 160, Issue 1, 2002, Pages 177-184

  Bayerle Eder, Michaela ^a   Fuchsjäger Mayrl, Gabriele ^a   Sieder, Anna ^a   Polska, Elzbieta ^a   Roden, Michael ^a   Stulnig, Thomas ^a   Bischof, Martin G ^a   Waldhäusl, Werner ^a   Schmetterer, Leopold ^a,b   Wolzt, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial function; Fundus pulsation amplitude; Hypercholesterolaemia; L NMMA; Nitric oxide; Pravastatin

Indexed keywords

4 AMINOHIPPURIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; PLACEBO; PRAVASTATIN;

ADULT; ARTICLE; BLOOD FLOW; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INTERFEROMETRY; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; PLEIOTROPY; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTILIPEMIC AGENTS; AUSTRALIA; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; KIDNEY; MALE; MIDDLE AGED; OMEGA-N-METHYLARGININE; PRAVASTATIN; TIME FACTORS; TRIGLYCERIDES;

EID: 0036147355     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00559-7     Document Type: Article

References (50)

1. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study
2. The evolving role of statins in the management of atherosclerosis
3. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
4. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease
5. Are there potential non-lipid-lowering uses of statins?
6. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
7. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia
8. Cholesterol lowering and endothelial function
9. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
10. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men
11. Does lowering of cholesterol levels influence functional properties of large arteries?
12. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: Association with cardiovascular events
13. Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness
14. The kinetic properties of very low density lipoprotein triglyceride in type 3 hyperlipoproteinemia
15. Comparison of non-invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: Sex differences in cardiovascular responsiveness
16. Topical fundus pulsation measurement
17. Ocular blood flow and associated functional deviations in diabetic retinopathy
18. Noninvasive investigations of the normal ocular circulation in humans
19. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers
20. The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men
21. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
22. Simplified measurement of p-aminohippurate and other arylamines in plasma and urine
23. Measurement of renal clearance of inulin and PAH in the steady state without urine collection
24. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans
25. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans
26. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin
27. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans
28. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
29. Regulation of endothelial NO production by Rho GTPase
30. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects
31. Neuroprotective properties of statins in cerebral ischemia and stroke
32. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
33. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment
34. Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia
35. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
36. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor
37. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: Reversal by L-arginine
38. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans
39. Differences in onset of impaired endothelial responses and in effects of vitamin E in the hypercholesterolemic rabbit carotid and renal arteries
40. Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension
41. Tissue-selective uptake of pravastatin in rats: Contribution of a specific carrier-mediated uptake system
42. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types
43. Tissue selective drug delivery utilizing carrier-mediated transport systems
44. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
45. Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin
46. Effect of a single high-fat meal on endothelial function in healthy subjects
47. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
48. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome
49. Insulin resistance and endothelial dysfunction in smokers: Effects of vitamin C
50. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes